Dan Akschuti

Dan Akschuti is an experienced biotech analyst and equity partner at Pareto Securities since August 2019, specializing in evaluating investment opportunities and supporting investment banking decisions through comprehensive analyses of biotech companies, primarily in the Nordic and Swiss regions. Previously, Dan co-founded Beijing DSF Biotech Ltd., managing negotiations for exclusive distribution rights in China and conducting thorough market analysis and due diligence. Dan also contributed to drug development at Novartis, progressing from trainee to senior scientist over six years, and provided support in pre-IND development activities for early-phase biologics. Dan's educational background includes a Master's in Bioentrepreneurship from Karolinska Institutet, a CFA certification, and a Bachelor's in Molecular Life Sciences.